Literature DB >> 22968423

[Demands on dialysis access from the nephrologists point of view].

U Ott1, H Sperschneider.   

Abstract

Vascular access is the lifeline of hemodialysis patients. The superiority of autogenous arteriovenous fistulas compared to prostethic arteriovenous grafts or a central venous catheter is well established. Fistulas have a far lower risk of failure and a reduced requirement for revision compared to prosthetic grafts. Alternative vascular access can be achieved via a prosthetic graft or permanent central venous catheter but the risk of infection is increased. The most important complications are shunt thrombosis, stenosis, aneurysms or steal syndrome. Signs of these complications should be recognized by the dialysis team and early surgical intervention can avoid major complications. In many cases a complex shunt is necessary if the patient has been on dialysis for a long time. Interaction between the dialysis team, nephrologists, surgeons and interventional radiologists can improve the prognosis of dialysis patient.

Entities:  

Mesh:

Year:  2012        PMID: 22968423     DOI: 10.1007/s00104-012-2302-1

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  6 in total

1.  Antiplatelet therapy and vascular-access patency.

Authors:  Charmaine E Lok
Journal:  N Engl J Med       Date:  2009-05-21       Impact factor: 91.245

2.  Vascular access use in Europe and the United States: results from the DOPPS.

Authors:  Ronald L Pisoni; Eric W Young; Dawn M Dykstra; Roger N Greenwood; Erwin Hecking; Brenda Gillespie; Robert A Wolfe; David A Goodkin; Philip J Held
Journal:  Kidney Int       Date:  2002-01       Impact factor: 10.612

3.  Predictors of adequacy of arteriovenous fistulas in hemodialysis patients.

Authors:  P E Miller; A Tolwani; C P Luscy; M H Deierhoi; R Bailey; D T Redden; M Allon
Journal:  Kidney Int       Date:  1999-07       Impact factor: 10.612

4.  Effect of dipyridamole plus aspirin on hemodialysis graft patency.

Authors:  Bradley S Dixon; Gerald J Beck; Miguel A Vazquez; Arthur Greenberg; James A Delmez; Michael Allon; Laura M Dember; Jonathan Himmelfarb; Jennifer J Gassman; Tom Greene; Milena K Radeva; Ingemar J Davidson; T Alp Ikizler; Gregory L Braden; Andrew Z Fenves; James S Kaufman; James R Cotton; Kevin J Martin; James W McNeil; Asif Rahman; Jeffery H Lawson; James F Whiting; Bo Hu; Catherine M Meyers; John W Kusek; Harold I Feldman
Journal:  N Engl J Med       Date:  2009-05-21       Impact factor: 91.245

5.  Timing of arteriovenous fistula placement and Medicare costs during dialysis initiation.

Authors:  Craig A Solid; Caroline Carlin
Journal:  Am J Nephrol       Date:  2012-05-11       Impact factor: 3.754

6.  Dialysis access dysfunction.

Authors:  Alexander Yevzlin; Arif Asif; Anil K Agarwal
Journal:  Int J Nephrol       Date:  2012-04-12
  6 in total
  1 in total

1.  Neutrophil extracellular traps and heparin-induced antibodies contribute to vascular access thrombosis in hemodialysis patients.

Authors:  Hoi Woul Lee; Jung Nam An; Hyung Seok Lee; Young Rim Song; Hyung Jik Kim; Sung Gyun Kim; Jwa-Kyung Kim
Journal:  Kidney Res Clin Pract       Date:  2021-08-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.